Sun Pharmaceutical Industries reported a net profit of Rs 3,117.95 crore for Q2 FY26, a 2.6% year-on-year increase. Revenue from operations grew 8.6% to Rs 14,405.22 crore, with U.S. Innovative Medicines sales surpassing Generics for the first time. The company’s R&D investment stood at 5.4% of sales.Read More
Nomura and Nuvama reiterated ‘Buy’ ratings on Mahindra & Mahindra after strong Q2 results, projecting up to 22% upside on robust SUV demand, farm segment growth, and rising margins driven by new launches and PLI benefits.Read More
Japan’s Nikkei share average fell 2.5% on Wednesday, mirroring Wall Street’s overnight declines, with technology stocks leading the losses. The index dropped as much as 4.65% before recovering slightly, as investors eyed potential buying opportunities below the 50,000 mark. Despite the dip, analysts anticipate a slow but steady rise for the Nikkei in the future.Read More
European shares dipped to a two-week low on Wednesday, mirroring global investor nervousness over elevated equity valuations. Technology stocks led the decline, while Novo Nordisk slipped after issuing a cautious profit forecast. However, Vestas shares surged on better-than-expected earnings.Read More
Edtech firm PhysicsWallah will open its Rs 3,480 crore IPO on 11 November. Backed by WestBridge Capital, the company reported strong revenue growth and narrowing losses in FY25.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
